ESG risk score 25.6
Environmental score 4.35
Social score 15.13
Governance score 6.11
ESG risk category Medium
Negligible Low Med High Severe
0-10 10-20 20-30 30-40 40+
Organon & Company
000.00
0.00 / 0.00%
00:00:00
52 week range
0000.00 000.00
Symbol OGN:xnys
Currency USD
New York Stock Exchange
Open Closed
15 minutes delayed
Data provided by 
This information is not currently available for this instrument. Refresh the page or try again later.
Want to start investing?
Trade stocks with a broker trusted by over 1.5 million clients. Investing involves risk. You may lose some or all of your investment.
Chart
This information is not currently available for this instrument. Refresh the page or try again later.
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
This information is not currently available for this instrument. Refresh the page or try again later.
Returns
Year to date (YTD) -15.62%
1 year -53.64%
3 years -74.74%
Data provided by 
Key stats
Price/earnings (LTM) 8.44
Dividend yield (LTM) 5.62%
EPS (LTM) 0.72
Volatility (30 days) 34.48%
Data provided by
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Data provided by 
/ 
/ Financials
Q1 Q2 Q3 Q4
Income statement
Revenue XXXXXXX XXXXXXX XXXXXXX XXXXXXX
EBITDA XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Net income XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Balance sheet
Total assets XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Total debt XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Ratios
Price/sales XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Earnings per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Dividend per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Return on equity XXXXXXX XXXXXXX XXXXXXX XXXXXXX
About Organon & Company
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
Sector Healthcare
Industry -
Market cap 2bn
Data provided by /
/ Others were interested in
See all stocksFrequently asked questions
To buy Organon & Company stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Organon & Company by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Organon & Company is OGN:xnys. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Organon & Company has its primary listing on New York Stock Exchange. You can trade Organon & Company with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Organon & Company is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Organon & Company as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Organon & Company or others.